Prognostic value of pre-treatment serum CA19-9 and lymphocyte-to-monocyte ratio in HR+/HER2- breast cancer: a retrospective cohort study.

BMC Cancer · 2026 · PMC13170149 · PMID 41918082

Europe PMC DOI

hedged sentence

0.0950

closest p · 1.9× alpha

0.0950

boldest claim

The sentences

did not reach statistical significanceP = 0.095so close (0.05 < p ≤ 0.1)

Among patients who did not receive postoperative radiotherapy, high CA19-9 remained significantly associated with reduced OS ( P = 0.012), whereas low LMR showed a similar trend that did not reach statistical significance ( P = 0.095), possibly due to the small sample size (Fig. 5 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.